ADO
Click for more information
23.1% 3.2¢ anteotech ltd

Interestingly, " how long do you think Covid testing will be...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. Charles89
    4,995 Posts.
    lightbulb Created with Sketch. 2157
    clock Created with Sketch.
    15/12/21
    12:46
    Post #: 58308059
    Interestingly, " how long do you think Covid testing will be required", is only part of the question.

    As you said, investment based on EuGeni roll-out, but in the short/medium term, EuGeni will have a suite of different tests that is not just Covid-19 related, therefore, IMO the longer term or the more sustainable question should be:

    How many other addressable conditions/virus/market can EuGeni serve?

    EuGeni's RAT is just one of many.
    ADO Price at posting: 17.3¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 26  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS ClearVue successfully raises $7.5 million via institutional placement
right-arrow Created with Sketch.
SBW Shekel Brainweigh reports a 50% revenue increase in its Retail Innovation suite and delivers the first batch of 20 Smart Bays to Hitachi as part of a larger order
right-arrow Created with Sketch.
NEWS Achilles returns further high grade silver-goldbase metal mineralisation
right-arrow Created with Sketch.
NEWS Scoping study unveils promising economics for the Ngami Copper Project, with potential copper resources up to 166Mt — find out more about what makes this a game-changer
right-arrow Created with Sketch.
NVU Nanoveu To Acquire Leading SoC Semiconductor Company
right-arrow Created with Sketch.
NEWS First-ever treatment for Rett syndrome approved in Canada, opening new possibilities for patients and boosting potential royalty payments—discover more about DAYBUE™'s breakthrough
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
3.2¢ 		Change
0.006(23.1%) 		Mkt cap ! $82.16M
Open High Low Value Volume
3.1¢ 3.7¢ 3.1¢ $1.249M 38.15M

Buyers (Bids)

No. Vol. Price($)
7 575343 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.3¢ 517273 3
View Market Depth
Last trade - 13.15pm 18/10/2024 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.